Downregulation of serotonergic gene expression in the raphe nuclei of the midbrain under chronic social defeat stress in male mice

Molecular Neurobiology

Volumn 48, Issue 1, 2013, Pages 13-21

  Boyarskikh, Ul'Yana A ^b   Bondar, Natalya P ^a   Filipenko, Maxim L ^b   Kudryavtseva, Natalia N ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

^b INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

Author keywords

Chronic social defeat stress; Htr1a; Maoa; Sert; Tph2

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESSENGER RNA; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2 RATE LIMITING ENZYME; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; AVOIDANCE BEHAVIOR; GENE EXPRESSION; MALE; MESENCEPHALON; MIXED ANXIETY AND DEPRESSION; MOUSE; NEUROTRANSMISSION; NONHUMAN; RAPHE NUCLEUS; RECEPTOR DOWN REGULATION; REVIEW; RNA EXTRACTION; SEROTONINERGIC SYSTEM; SOCIAL STRESS;

EID: 84880919802     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8413-y     Document Type: Review

References (64)

1. Kudryavtseva NN, Avgustinovich DF (1998) Behavioral and physiological markers of experimental depression induced by social conflicts (DISC). Aggress Behav 24:271-286
2. Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12(Suppl 1):2-19
3. Avgustinovich DF, Alekseyenko OV, Bakshtanovskaya IV, Koryakina LA, Lipina TV et al (2004) Dynamic changes of brain serotonergic and dopaminergic activities during development of anxious depression: experimental study. Usp Fiziol Nauk 35:19-40
4. Lowry CA, Hale MW, Evans AK, Heerkens J, Staub DR et al (2008) Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci 1148:86-94
5. Carr GV, Lucki I (2011) The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology (Berl) 213:265-287
6. Kudryavtseva NN, Bakshtanovskaya IV, Koryakina LA (1991) Social model of depression in mice of C57BL/6J strain. Pharmacol Biochem Behav 38:315-320
7. Filipenko ML, Alekseyenko OV, Beilina AG, Kamynina TP, Kudryavtseva NN (2001) Increase of tyrosine hydroxylase and dopamine transporter mRNA levels in ventral tegmental area of male mice under influence of repeated aggression experience. Brain Res Mol Brain Res 96:77-81
8. Filipenko ML, Beilina AG, Alekseyenko OV, Dolgov VV, Kudryavtseva NN (2002) Increase in expression of brain serotonin transporter and monoamine oxidase a genes induced by repeated experience of social defeats in male mice. Biochemistry (Mosc) 67:451-455
9. Goloshchapov AV, Filipenko ML, Bondar NP, Kudryavtseva NN, Van Ree JM (2005) Decrease of kappa-opioid receptor mRNA level in ventral tegmental area of male mice after repeated experience of aggression. Brain Res Mol Brain Res 135:290-292
10. Kudryavtseva NN, Filipenko ML, Bakshtanovskaya IV, Avgustinovich DF, Alekseenko OV et al (2004) Changes in the expression of monoaminergic genes under the influence of repeated experience of agonistic interactions: from behavior to gene. Russ J Genet 40:590-604
11. Abumaria N, Rygula R, Hiemke C, Fuchs E, Havemann-Reinecke U et al (2007) Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat. Eur Neuropsychopharmacol 17:417-429
12. Sulser F (2002) The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression. Ann Med 34:348-356
13. Blendy JA (2006) The role of CREB in depression and antidepressant treatment. Biol Psychiatry 59:1144-1150
14. Greenberg ME, Xu B, Lu B, Hempstead BL (2009) New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 29:12764-12767
15. D'Sa C, Duman RS (2002) Antidepressants and neuroplasticity. Bipolar Disord 4:183-194
16. Gass P, Riva MA (2007) CREB, neurogenesis and depression. Bioessays 29:957-961
17. Avgustinovich DF, Kovalenko IL, Kudryavtseva NN (2005) A model of anxious depression: persistence of behavioral pathology. Neurosci Behav Physiol 35:917-924
18. Kudryavtseva NN (2010) Sensory contact model: protocol, control, applications. Nova Science Publishers, Inc, New York, p 38
19. Rosen GD, Williams AG, Capra JA, Connolly MT, Cruz B, et al. (2000) The Mouse Brain Library @ www.mbl.org. Int Mouse Genome Conference 14: 166. www.mbl.org
20. Cook NL, Vink R, Donkin JJ, van den Heuvel C (2009) Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury. J Neurosci Res 87:34-41
21. Chari R, Lonergan KM, Pikor LA, Coe BP, Zhu CQ et al (2010) A sequence-based approach to identify reference genes for gene expression analysis. BMC Med Genomics 3:32
22. Valente V, Teixeira SA, Neder L, Okamoto OK, Oba-Shinjo SM et al (2009) Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR. BMC Mol Biol 10:17
23. Wierschke S, Gigout S, Horn P, Lehmann TN, Dehnicke C et al (2010) Evaluating reference genes to normalize gene expression in human epileptogenic brain tissues. Biochem Biophys Res Commun 403:385-390
24. Otis JP, Ackermann LW, Denning GM, Carey HV (2010) Identification of qRT-PCR reference genes for analysis of opioid gene expression in a hibernator. J Comp Physiol B 180:619-629
25. Passmore M, Nataatmadja M, Fraser JF (2009) Selection of reference genes for normalisation of real-time RT-PCR in brain-stem death injury in Ovis aries. BMC Mol Biol 10:72
26. Castren E, Rantamaki T (2010) The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 70:289-297
27. Duman RS (2009) Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci 11:239-255
28. Hashimoto K (2010) Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci 64:341-357
29. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ et al (2002) Neurobiology of depression. Neuron 34:13-25
30. Thakker-Varia S, Alder J (2009) Neuropeptides in depression: role of VGF. Behav Brain Res 197:262-278
31. Pizarro JM, Lumley LA, Medina W, Robison CL, Chang WE et al (2004) Acute social defeat reduces neurotrophin expression in brain cortical and subcortical areas in mice. Brain Res 1025:10-20
32. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL et al (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525
33. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W et al (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868
34. Krishnan V, Han MH, Graham DL, Berton O, Renthal W et al (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391-404
35. Gomez-Lazaro E, Arregi A, Beitia G, Vegas O, Azpiroz A et al (2011) Individual differences in chronically defeated male mice: behavioral, endocrine, immune, and neurotrophic changes as markers of vulnerability to the effects of stress. Stress 14:537-548
36. Kudryavtseva NN, Bondar NP, Boyarskikh UA, Filipenko ML (2010) Snca and Bdnf gene expression in the VTA and raphe nuclei of midbrain in chronically victorious and defeated male mice. PLoS One 5:e14089
37. Kudryavtseva NN, Bakshtanovskaya IV (1988) The development of a depression-like state in submissive male mice of C57BL/6J strain. Institute of Cytology and Genetics SD RAS, Novosibirsk, p 39
38. Miczek KA, Yap JJ, Covington HE 3rd (2008) Social stress, therapeutics and drug abuse: preclinical models of escalated and depressed intake. Pharmacol Ther 120:102-128
39. Kalueff AV, Avgustinovich DF, Kudryavtseva NN, Murphy DL (2006) BDNF in anxiety and depression. Science 312:1598-1599, author reply 1598-1599
40. Rios M, Fan G, Fekete C, Kelly J, Bates B et al (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15:1748-1757
41. Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP et al (2005) Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180:95-99
42. Dwivedi Y, Rizavi HS, Pandey GN (2006) Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139:1017-1029
43. Yu H, Chen ZY (2011) The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 32:3-11
44. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079-1088
45. Gray JD, Milner TA, McEwen BS (2012) Dynamic plasticity: the role of glucocorticoids, brain-derived neurotrophic factor and other trophic factors. Neuroscience. doi: 10.1016/j.neuroscience.2012.08.034 Aug 23. (Review)
46. Kimpton J (2012) The brain derived neurotrophic factor and influences of stress in depression. Psychiatr Danub 24(Suppl 1):S169-S171, Review
47. Tapia-Arancibia L, Rage F, Givalois L, Arancibia S (2004) Physiology of BDNF: focus on hypothalamic function. Front Neuroendocrinol 25(2):77-107, Review
48. Schaaf MJ, De Kloet ER, Vreugdenhil E (2000) Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress 3(3):201-208, Review
49. Boer U, Alejel T, Beimesche S, Cierny I, Krause D et al (2007) CRE/CREB-driven up-regulation of gene expression by chronic social stress in CRE-luciferase transgenic mice: reversal by antidepressant treatment. PLoS One 2:e431
50. Abumaria N, Rygula R, Havemann-Reinecke U, Ruther E, Bodemer W et al (2006) Identification of genes regulated by chronic social stress in the rat dorsal raphe nucleus. Cell Mol Neurobiol 26:145-162
51. Carlezon WA Jr, Duman RS, Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28:436-445
52. Spangler R, Ho A, Zhou Y, Maggos CE, Yuferov V et al (1996) Regulation of kappa opioid receptor mRNA in the rat brain by "binge" pattern cocaine administration and correlation with preprodynorphin mRNA. Brain Res Mol Brain Res 38:71-76
53. Azaryan AV, Clock BJ, Rosenberger JG, Cox BM (1998) Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol 76:278-283
54. Nikulina EM, Hammer RP Jr, Miczek KA, Kream RM (1999) Social defeat stress increases expression of mu-opioid receptor mRNA in rat ventral tegmental area. Neuroreport 10:3015-3019
55. Crespo JA, Manzanares J, Oliva JM, Corchero J, Palomo T et al (2001) Extinction of cocaine self-administration produces a differential time-related regulation of proenkephalin gene expression in rat brain. Neuropsychopharmacology 25:185-194
56. Nichols CD, Garcia EE, Sanders-Bush E (2003) Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Brain Res Mol Brain Res 111:182-188
57. Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M et al (2010) BDNF function and intracellular signaling in neurons. Histol Histopathol 25:237-258
58. Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33:73-83
59. Avgustinovich DF, Alekseyenko OV, Tenditnik MV (2001) Fighting among C57BL/6J mice and its implications for [3H]8-hydroxy-N, N-dipropyl-2- aminotetralin binding in various brain regions. Neurosci Lett 305:189-192
60. Avgustinovich DF, Lipina TV, Molodtsova GF, Alekseenko OV, Koriakina LA et al (1998) Change of tryptophan hydroxylase and monoamine oxidase A activities in experimental depression induced by social confrontation. Dokl Akad Nauk 363:405-408
61. Kudryavtseva NN, Avgustinovich DF (2006) Molecular mechanisms of social behavior: comments to the paper of Berton et al. 2006. Russ J Neurosci 4:33-35
62. 22222Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ et al (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361:653-661
63. Thase ME (2006) Preventing relapse and recurrence of depression: a brief review of therapeutic options. CNS Spectr 11:12-21
64. Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M et al (2007) A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technol Assess 11:iii-iv, ix-206 Biology"